Logo image
Sign in
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial
Journal article   Open access  Peer reviewed

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

Michael Szarek, Harvey D White, Gregory G Schwartz, Marco Alings, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, …
02/05/2019

Abstract

acute coronary syndrome ACUTE CORONARY SYNDROMES alirocumab Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology Life Sciences & Biomedicine REDUCTION Science & Technology STATIN THERAPY total events
url
https://doi.org/10.1016/j.jacc.2018.10.039View
Published (Version of record) Open

Details